Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

232 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interstitial biodegradable balloon for reduced rectal dose during prostate radiotherapy: results of a virtual planning investigation based on the pre- and post-implant imaging data of an international multicenter study.
Melchert C, Gez E, Bohlen G, Scarzello G, Koziol I, Anscher M, Cytron S, Paz A, Torre T, Bassignani M, Dal Moro F, Jocham D, Yosef RB, Corn BW, Kovács G. Melchert C, et al. Among authors: jocham d. Radiother Oncol. 2013 Feb;106(2):210-4. doi: 10.1016/j.radonc.2013.01.007. Epub 2013 Feb 26. Radiother Oncol. 2013. PMID: 23484879
Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: a prospective multi-center study.
Gez E, Cytron S, Ben Yosef R, London D, Corn BW, Alani S, Scarzello G, Dal Moro F, Sotti G, Zattoni F, Koziol I, Torre T, Bassignani M, Kalnicki S, Ghavamian R, Blakaj D, Anscher M, Sommerauer M, Jocham D, Melchert C, Huttenlocher S, Kovacs G, Garg M. Gez E, et al. Among authors: jocham d. Radiat Oncol. 2013 Apr 23;8:96. doi: 10.1186/1748-717X-8-96. Radiat Oncol. 2013. PMID: 23618548 Free PMC article. Clinical Trial.
Results of multiparametric transrectal ultrasound-based focal high-dose-rate dose escalation combined with supplementary external beam irradiation in intermediate- and high-risk localized prostate cancer patients.
Kovács G, Müller K, Soror T, Melchert C, Guo X, Jocham D, Merseburger A. Kovács G, et al. Among authors: jocham d. Brachytherapy. 2017 Mar-Apr;16(2):277-281. doi: 10.1016/j.brachy.2016.11.005. Epub 2016 Dec 7. Brachytherapy. 2017. PMID: 27964906
Technology evaluation: Onyvax-P, Onyvax.
Doehn C, Böhmer T, Jocham D. Doehn C, et al. Among authors: jocham d. Curr Opin Mol Ther. 2005 Oct;7(5):511-9. Curr Opin Mol Ther. 2005. PMID: 16248287 Review.
Degarelix for prostate cancer.
Doehn C, Sommerauer M, Jocham D. Doehn C, et al. Among authors: jocham d. Expert Opin Investig Drugs. 2009 Jun;18(6):851-60. doi: 10.1517/13543780902954713. Expert Opin Investig Drugs. 2009. PMID: 19453267 Review.
232 results